Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoe Fleischmann

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
JCO Precision Oncology|September 28, 2023
Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor ResponseJay A Moore, Kuei-Ting Chen, Russell Madison, et al.
Cancer Research Communications|August 8, 2024
Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic FeaturesN Ari Wijetunga, Kathryn H Gessner, Krishna Kanchi, et al.
The Journal of Molecular Diagnostics : JMD|January 4, 2026
Phenotypic POLE variant classification identifies patients who may have favorable prognosis and benefit from immunotherapyRachel B Keller-Evans, Zoe Fleischmann, Smruthy Sivakumar, et al.
The Journal of Molecular Diagnostics : JMD|August 22, 2025
High-Specificity Detection of UV Mutational Signatures in Circulating Tumor DNA for Diagnostic Classification of Cutaneous and Unknown Primary Tumors Using FoundationOne Liquid CDxDouglas A Mata, Angela A Kou, Andreas M Heilmann, et al.
Nucleic Acids Research|September 21, 2022
A mitochondria-specific mutational signature of aging: increased rate of A > G substitutions on the heavy strandAlina G Mikhailova, Alina A Mikhailova, Kristina Ushakova, et al.
European Urology Oncology|December 10, 2023
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate CancerJacob J Orme, Fadi Taza, Navonil De Sarkar, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
JCO Precision Oncology|September 28, 2023
Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor ResponseJay A Moore, Kuei-Ting Chen, Russell Madison, et al.
Cancer Research Communications|August 8, 2024
Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic FeaturesN Ari Wijetunga, Kathryn H Gessner, Krishna Kanchi, et al.
The Journal of Molecular Diagnostics : JMD|January 4, 2026
Phenotypic POLE variant classification identifies patients who may have favorable prognosis and benefit from immunotherapyRachel B Keller-Evans, Zoe Fleischmann, Smruthy Sivakumar, et al.
The Journal of Molecular Diagnostics : JMD|August 22, 2025
High-Specificity Detection of UV Mutational Signatures in Circulating Tumor DNA for Diagnostic Classification of Cutaneous and Unknown Primary Tumors Using FoundationOne Liquid CDxDouglas A Mata, Angela A Kou, Andreas M Heilmann, et al.
Nucleic Acids Research|September 21, 2022
A mitochondria-specific mutational signature of aging: increased rate of A > G substitutions on the heavy strandAlina G Mikhailova, Alina A Mikhailova, Kristina Ushakova, et al.
European Urology Oncology|December 10, 2023
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate CancerJacob J Orme, Fadi Taza, Navonil De Sarkar, et al.
Pageof 2